Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H27FN2O2 |
| Molecular Weight | 345.4415 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)[C@H]1CCCC2=C1C3=C(OC)C=CC=C3N2CC[18F]
InChI
InChIKey=ZVDVQPLDTTXLKI-LSKWOKDISA-N
InChI=1S/C20H27FN2O2/c1-4-22(5-2)20(24)14-8-6-9-15-18(14)19-16(23(15)13-12-21)10-7-11-17(19)25-3/h7,10-11,14H,4-6,8-9,12-13H2,1-3H3/t14-/m0/s1/i21-1
Flutriciclamide F18 (18F-GE-180), a translocator protein (TSPO)-PET radiotracer was used using in different pathologies. This agent was studied in phase I clinical trial to assess inflammation in rheumatoid arthritis. However, this study was terminated because of the pre-defined stopping criteria in the protocol.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Neuroinflammation Appears Early on PET Imaging and Then Plateaus in a Mouse Model of Alzheimer Disease. | 2018-03 |
|
| Flutriciclamide (18F-GE180) PET: First-in-Human PET Study of Novel Third-Generation In Vivo Marker of Human Translocator Protein. | 2016-11 |
|
| In Vivo Detection of Age- and Disease-Related Increases in Neuroinflammation by 18F-GE180 TSPO MicroPET Imaging in Wild-Type and Alzheimer's Transgenic Mice. | 2015-11-25 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02350426
18F-GE-180 solution for IV injection in 10mL glass vial. Patients will receive a maximum activity of 195 MBq in a maximum volume of 10 mL (bolus) of 18F-GE-180, containing not more than 2 microgram (mcg)/mL 18F-GE-180 (20 mcg for a 10 mL dose).
Route of Administration:
Intravenous
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
51040949
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
9649
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
DB15380
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
1274863-98-7
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
300000037060
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
C174700
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY | |||
|
M96ARL6373
Created by
admin on Mon Mar 31 21:52:20 GMT 2025 , Edited by admin on Mon Mar 31 21:52:20 GMT 2025
|
PRIMARY |
ACTIVE MOIETY